Drug-Related Side Effects and Adverse Reactions
"Drug-Related Side Effects and Adverse Reactions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals.
|Drug-Related Side Effects and Adverse Reactions
- Drug-Related Side Effects and Adverse Reactions
- Drug Related Side Effects and Adverse Reactions
- Side Effects of Drugs
- Drug Side Effects
- Drug Side Effect
- Effects, Drug Side
- Side Effect, Drug
- Side Effects, Drug
- Adverse Drug Reaction
- Adverse Drug Reactions
- Drug Reaction, Adverse
- Drug Reactions, Adverse
- Reactions, Adverse Drug
- Adverse Drug Event
- Adverse Drug Events
- Drug Event, Adverse
- Drug Events, Adverse
- Drug Toxicity
- Toxicity, Drug
- Drug Toxicities
- Toxicities, Drug
Below are MeSH descriptors whose meaning is more general than "Drug-Related Side Effects and Adverse Reactions".
Below are MeSH descriptors whose meaning is more specific than "Drug-Related Side Effects and Adverse Reactions".
This graph shows the total number of publications written about "Drug-Related Side Effects and Adverse Reactions" by people in this website by year, and whether "Drug-Related Side Effects and Adverse Reactions" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Drug-Related Side Effects and Adverse Reactions" by people in Profiles.
Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study. Lung Cancer. 2023 04; 178:166-171.
Advances in Multimodality Imaging in?Cardio-Oncology: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022 10 18; 80(16):1560-1578.
Efficacy and Safety of Ivarmacitinib in Patients With Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study. Gastroenterology. 2022 12; 163(6):1555-1568.
Hispanic ethnicity and the rs4880 variant in SOD2 are associated with elevated liver enzymes and bilirubin levels in children receiving asparaginase-containing chemotherapy for acute lymphoblastic leukemia. Biomed Pharmacother. 2022 Jun; 150:113000.
Efficacy and tolerability of the modified Atkins diet in children with drug-resistant genetic generalized epilepsy. Epileptic Disord. 2022 Apr 01; 24(2):295-301.
Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing. Cancer. 2022 Apr 15; 128(8):1649-1657.
Legal settlements and the reporting of adverse drug events: Insights from the aripiprazole products liability litigation. Psychiatry Res. 2022 03; 309:114411.
Electronic Health Record Interoperability-Why Electronically Discontinued Medications Are Still Dispensed. JAMA Intern Med. 2021 10 01; 181(10):1383-1384.
The Risks of Reflexive Refilling. WMJ. 2021 Oct; 120(3):237-240.
Dose Optimization of Sotorasib: Is the US Food and Drug Administration Sending a Message? J Clin Oncol. 2021 11 01; 39(31):3423-3426.